Categories: AnalystsCannabis

Senate cannabis bill should pass, analyst says

Cannabis industry players and investors alike are waiting anxiously for the results of a Senate vote Thursday evening, which will determine the fate of the Liberal government’s proposed marijuana legislation. Although sources say the vote could be tight, equity research analyst Vahan Ajamian says that even without a whip on independent senators in the Red Chamber and Conservative senators voting en masse, the bill is still likely to pass.

Tonight, the Senate will vote on its second reading of Bill C-45, the so-called Cannabis Act, which would effectively legalize the recreational use of marijuana and, in the process, give birth to a whole new (legal) sector of the economy.

A majority of the 105 senators are reportedly in favour of the criminal code amendment but with a number of independently-sitting senators currently out of Ottawa on committee work and with 33 Conservative senators promising to vote together against the bill, the count could be tighter than expected.

If a bill gets defeated at second reading, the legislation is effectively dead, leaving the Liberal government no choice but to wait and propose new legislation during the next session. That would almost certainly kill the idea of a legal recreational market opening up this summer and put a damper on the plans of a number of cannabis cultivators and their investors.

But, speaking with BNN, Ajamian of investment dealer Beacon Securities says that’s likely not going to happen and that the bill will pass, in part because Prime Minister Justin Trudeau and his Liberal party would likely have already impressed upon Liberal and independent senators alike the fact that the act represents a central campaign promise that both PM and party would want to push ahead with.

“The current system does not work,” said Trudeau recently at an event in New Brunswick. “This is not something that Canadians want to see continued.”

Nevertheless, Conservative senators have so far been vocal in opposition to the bill, questioning especially the speed at which the government is attempting to push through C-45 and its associated legislation on impaired driving, Bill C-46.

“Both bills are shoddily constructed and raise a myriad of unanswered questions that will lead to unintended and devastating consequences,” said Conservative Saskatchewan Sen. Denise Batters on Tuesday. “Honourable senators, this is too high a price for Canadians to pay simply to satisfy Prime Minister Trudeau’s political ambitions. For all of these reasons, I will vote against Bill C-45 at second reading.”

“We, the select few with sober second thought, should not consider saying ‘yes’ to this odious legislation until we, on behalf of all Canadians, have all the answers,” said Conservative Alberta Sen. Betty Unger. “I believe that, at a minimum, an intensive four-year education blitz should begin now before any government contemplates legislation.”

If passed, Bill C-45 will move onto a third Senate reading scheduled for early June, after which the government has suggested a period of eight to 12 weeks to allow various retail networks to get up and running, altogether pushing the date of first sale sometime into August

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

5 hours ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

6 hours ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

6 hours ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago